Skip to content
Home/Companies/Biotech/The Native Antigen Company
NA

The Native Antigen Company

Biotech·UK·Exited 2020·Held 6yr

The Native Antigen Company is a biotech company, headquartered in UK.

Entry
2014
Hold
6yr
Exit
2020
Est. EV
–

Who owns The Native Antigen Company?

The Native Antigen Company was owned by Mercia Asset Management through Mercia Direct Investments (2014 vintage) from 2014 to 2020, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-06-01

Mercia Asset Management
Investor
Mercia Asset Management
Mercia Direct Investments · 2014 · Balance Sheet

Key facts

HQUK
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2020

More from Mercia Direct Investments

Other portfolio companies in the same fund.

Axis Spine Technologies
Active
MedTechUK· 2022
Netacea
Active
CybersecurityUK· 2022
Nova Pangaea
Active
ClimateTechUK· 2022
Locate Bio
Active
BiotechUK· 2021
Pimberly
Active
SaaSUK· 2021
Clear Review
Exited 2020
HR TechUK· 2019
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings